Translating mechanisms of GLP-1RAs and SGLT2 inhibitors to CV benefits

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Lecture: Screening for Diabetes: When is it meaningful and how should it be performed
Lecture: Screening for Diabetes: When is it meaningful and how should it be performed
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Screening for Diabetes: When is it meaningful and how should it be performed
- Prof. Lars Rydén
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
- Prof. Richard Hobbs, MD
Lecture: Shifting gears in CVD & T2DM: What is the rationale for new diabetes interventions in the course of CVD?
Lecture: Shifting gears in CVD & T2DM: What is the rationale for new diabetes interventions in the course of CVD?
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Shifting gears in CVD & T2DM: What is the rationale for new diabetes interventions in the course of CVD?
- Prof John E Deanfield
Lecture: Diabetes: The new challenge in cardiovascular risk management
Lecture: Diabetes: The new challenge in cardiovascular risk management
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Diabetes: The new challenge in cardiovascular risk management
- Prof. Lars Rydén